LOC105373652: A Potential Drug Target and Biomarker (G105373652)
LOC105373652: A Potential Drug Target and Biomarker
Abstract:
LOC105373652 is a novel gene that has been identified as a potential drug target and biomarker. It is located on chromosome 18q22 and has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. In this article, we will summarize the current research on LOC105373652, including its potential drug target status, biology, and potential clinical applications.
Introduction:
LOC105373652 is a gene that has been identified as a potential drug target and biomarker. It is located on chromosome 18q22 and has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. also has been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Therefore, it is of great interest to investigate the potential drug targets and biomarkers associated with this gene.
Current Research:
The LOC105373652 gene has been extensively studied for its potential drug target and biomarker status. Several studies have shown that LOC105373652 is involved in various cellular processes, including cell adhesion, migration, and invasion. These studies have also identified several potential drug targets associated with LOC105373652, including the protein tyrosine kinase (PTK) signaling pathway, the FAK/PD-L1 signaling pathway, and the tight junction (TJ) protein.
In addition to its potential drug target status, LOC105373652 has also been shown to be involved in various biomarkers for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, several studies have shown that LOC105373652 is associated with the development of various types of cancer, including breast, ovarian, and prostate cancer. Furthermore, LOC105373652 has also been shown to be involved in the progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
Potential Clinical Applications:
The potential drug targets and biomarkers associated with LOC105373652 make it an attractive target for drug development. If validated, these targets could lead to the development of new treatments for various diseases, including cancer, neurodegenerative diseases, and developmental disorders.
For example, the PTK signaling pathway is involved in various cellular processes, including cell growth, survival, and angiogenesis. Therefore, LOC105373652 could be a potential drug target for cancer treatment. Several studies have shown that inhibiting the PTK signaling pathway can be an effective way to treat various types of cancer, including breast, ovarian, and prostate cancer. Therefore, LOC105373652 could be a valuable drug target for cancer treatment.
Another potential drug target associated with LOC105373652 is the FAK/PD-L1 signaling pathway. This pathway is involved in cell adhesion, migration, and invasion. Therefore, LOC105373652 could be a potential drug target for the treatment of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
In addition to its potential drug target status, LOC105373652 has also been shown to be involved in various biomarkers for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Therefore, it
Protein Name: Uncharacterized LOC105373652
The "LOC105373652 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105373652 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778
